METAVIA INC. Operating Lease Right-of-Use Assets
METAVIA INC. (MTVA) had Operating Lease Right-of-Use Assets of $175.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-06
- 2026-06-30: Operating Lease, Right-of-Use Asset $175.00K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $193.00K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $210.00K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $76.00K.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $175.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $193.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $210.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $76.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $96.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $115.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $133.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $151.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $169.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $186.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $202.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $218.00K 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $99.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $105.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $111.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $117.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $123.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $130.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $100.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $105.00K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $143.00K 10-Q · filed 2020-05-20 | |
| 2019-12-31 | $150.00K 10-K · filed 2021-04-15 | |
| 2019-09-30 | $126.00K 10-K · filed 2020-03-30 | |
| 2019-06-30 | $18.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $44.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $9.00K 10-K · filed 2020-03-30 | $68.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |